
|Videos|May 22, 2020
AAN 2020 Data Release: Ofatumumab for Relapsing MS
Advertisement
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
CTAD Presentation Lays Insights Into Disappointing Phase 3 EVOKE Trial of GLP-1 Semaglutide in Alzheimer Disease
2
CTAD Poster Shows Etalanetug Reduced Tau Pathology Biomarkers in Dominantly Inherited Alzheimer Disease
3
New Phase 2 Trial to Test TREM2-Stabilizing Agent VHB937 in Alzheimer Disease
4
Alzheimer Trial PRImus-AD Tests Orally Available PRI-002 as New Treatment
5


































